当前位置:首页 - 行情中心 - 鲁抗医药(600789) - 财务分析 - 现金流量表

鲁抗医药

(600789)

  

流通市值:79.41亿  总市值:82.15亿
流通股本:10.10亿   总股本:10.45亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,575,466,803.11,268,662,185.395,116,633,874.443,758,129,493.31
  收到的税费返还19,613,930.1517,636,848.4634,497,737.2337,746,605.66
  收到其他与经营活动有关的现金55,367,249.5327,256,147119,255,037.06105,959,319.4
  经营活动现金流入小计2,650,447,982.781,313,555,180.855,270,386,648.733,901,835,418.37
  购买商品、接受劳务支付的现金1,659,186,581.59822,357,277.983,039,220,239.752,532,137,292.62
  支付给职工以及为职工支付的现金365,270,307.94189,944,925.81737,756,843.62530,362,214.65
  支付的各项税费88,559,682.3234,817,077.6188,908,016.59154,086,477.76
  支付其他与经营活动有关的现金178,631,755.68102,312,820.15606,327,699.75379,306,873.76
  经营活动现金流出小计2,291,648,327.531,149,432,101.544,572,212,799.713,595,892,858.79
  经营活动产生的现金流量净额358,799,655.25164,123,079.31698,173,849.02305,942,559.58
二、投资活动产生的现金流量:
  收回投资收到的现金--1,189,693.63-
  处置固定资产、无形资产和其他长期资产收回的现金净额18,812,647.7118,812,647.71104,201,617.5994,701,901.7
  投资活动现金流入小计18,812,647.7118,812,647.71105,391,311.2294,701,901.7
  购建固定资产、无形资产和其他长期资产支付的现金163,016,645.5538,303,519.16338,862,954.47209,213,507.48
  投资支付的现金1,161,360---
  投资活动现金流出小计164,178,005.5538,303,519.16338,862,954.47209,213,507.48
  投资活动产生的现金流量净额-145,365,357.84-19,490,871.45-233,471,643.25-114,511,605.78
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,186,829,138.68-
  取得借款收到的现金405,055,500349,547,5001,875,320,580.491,349,991,458.24
  收到其他与筹资活动有关的现金--100,000,000-
  筹资活动现金流入小计405,055,500349,547,5003,162,149,719.171,349,991,458.24
  偿还债务支付的现金1,012,455,702.35699,388,658.241,639,338,422.231,343,807,459.73
  分配股利、利润或偿付利息支付的现金24,924,826.2511,969,449.85167,300,555.68151,834,671.05
  其中:子公司支付给少数股东的股利、利润--1,002,800-
  支付其他与筹资活动有关的现金679,245.28679,245.28200,000,000-
  筹资活动现金流出小计1,038,059,773.88712,037,353.372,006,638,977.911,495,642,130.78
  筹资活动产生的现金流量净额-633,004,273.88-362,489,853.371,155,510,741.26-145,650,672.54
四、汇率变动对现金及现金等价物的影响-8,523,397.07-5,283,354.812,244,815.34,725,522.79
五、现金及现金等价物净增加额-428,093,373.54-223,141,000.321,622,457,762.3350,505,804.05
  加:期初现金及现金等价物余额2,118,158,954.32,118,158,954.3495,701,191.97495,701,191.97
  期末现金及现金等价物余额1,690,065,580.761,895,017,953.982,118,158,954.3546,206,996.02
补充资料:
  净利润145,987,096.15-111,906,367.03-
  资产减值准备23,751,147.07-45,731,523.35-
  固定资产和投资性房地产折旧194,280,555.06-384,169,213.68-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧194,280,555.06-384,169,213.68-
  无形资产摊销26,313,218.58-64,898,995.97-
  长期待摊费用摊销311,878.32-471,364.08-
  处置固定资产、无形资产和其他长期资产的损失-1,946.9--168,153.08-
  固定资产报废损失238,140.89-179,201.08-
  公允价值变动损失0-71,340-
  财务费用42,944,873.1-63,541,194.82-
  投资损失2,801,782.35-5,220,411.67-
  递延所得税-2,074,120.8--16,491,379.72-
  其中:递延所得税资产减少-2,074,120.8--16,491,379.72-
    递延所得税负债增加0---
  存货的减少-86,909,616.84-191,085,798.16-
  经营性应收项目的减少-158,680,403.4-169,326,364.6-
  经营性应付项目的增加154,579,264.29--331,301,202.67-
  其他--3,349,708.54-
  现金的期末余额1,690,065,580.76-2,118,158,954.3-
  减:现金的期初余额2,118,158,954.3-495,701,191.97-
  现金及现金等价物的净增加额-428,093,373.54-1,622,457,762.33-
公告日期2026-08-292026-04-252026-04-252025-10-31
审计意见(境内)标准无保留意见
TOP↑